A PHASE Ib STUDY EVALUATING THE SAFETY, EFFICACY, PHARMACOKINETICS AND PHARMACODYNAMICS OF GLOFITAMAB IN COMBINATION WITH GEMCITABINE PLUS OXALIPLATIN IN PATIENTS FROM RACIAL/ETHNIC MINORITIES WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
-
Enrollment
This study is currently enrolling. -
Associated Conditions
-
Research Area
Clinical Cancer Research -
Location
-
Principal Investigator
-
Sponsor
F. Hoffman-La Roche Ltd
The purpose of this study is to test glofitamab in Black and Hispanic/Latino participants to find out if it is safe, how well it works, and to understand the way your body processes the drug.
Enrollment Form
This study is currently enrolling.